Conn.'s Deposition Requests Limited In Zyprexa MDL

Law360, New York (May 4, 2009, 12:00 AM EDT) -- The magistrate judge overseeing discovery in the multidistrict litigation over Eli Lilly & Co.'s anti-psychotic drug Zyprexa ruled Monday that the state of Connecticut may only conduct witness depositions related to Zyprexa’s marketing and sales programs since 2004, a smaller scope of discovery than the state had requested.

In an order signed in the U.S. District Court for the Eastern District of New York, Magistrate Judge Roann L. Mann granted Connecticut’s request to seek testimony from Lilly representatives, but ruled that the state could not conduct...
To view the full article, register now.